INTRODUCTION
Epilepsy is a chronic non-communicable disorder of the brain that affects people of all age. Approximately, 50 million people worldwide have epilepsy making it one of the most common neurological disease globally. 1 One seizure does not signify epilepsy. It is defined as having two or more unprovoked seizures. It is characterized by recurrent seizures which are brief episodes of involuntary movement that may involve a part of the body (partial) or the entire body (generalized). Herbal remedies have been recommended in various medicinal treatises for the cure of different diseases. Present anticonvulsant drugs are efficacious in only about 75-80% of cases in general, and they also have their own adverse drug reactions such as gum hypertrophy, hirsutism, osteomalacia, sedation, diplopia, ataxia, and mood changes. In this regard, herbal based medicines are given much importance as they do not produce adverse effects. Hence, there is a need to conduct research for developing more efficacious and safer antiepileptic drugs. M. tuberosa has been extensively studied for its anti-diabetic, hepatoprotective, antidiarrhoeal in the past. Only a few studies have been conducted to evaluate its anticonvulsant activity of fruits. 6, 11 But no studies have been reported on its anticonvulsant property of leaves. Hence, this present study was taken to evaluate its anticonvulsant property in animal models.
METHODS

Plant material
Fresh green leaves of M. tuberosa popularly known as kasarakai were obtained in sufficient quantity from suburban places of Raichur in the month of August 2014. They were carefully washed to remove dust particles and other foreign materials and dried in shaded area, and it was authenticated by Mr. Harish. B. S. (Assistant Professor, Medicinal and Aromatic Crops) and the specimen (voucher number: SNMC/Pharma 007), is preserved for reference in the Department Herbarium of Pharmacology, SNMC Bagalkot.
Preparation of plant extract
The leaves of the plant were dried under shade for a period of 2-week. The dried leaves were milled to a fine powder. The material was extracted with 80% ethanol using soxhlet extraction apparatus, and it was evaporated to dry at 60°C. Dried leaves (20 g) of M. tuberosa leaves yielded 4 g of crude extract. The solid residues were stored in airtight container and preserved in the refrigerator at −20°C.
12 From this stock, fresh preparation was obtained whenever required.
Phytochemical analysis
Preliminary phytochemical studies of ethanolic extract of M. tuberosa leaves (EEMTL) revealed the presence of flavonoids, triterpenoids, steroids and carbohydrates.
13
Acute oral toxicity study
The acute toxoicity studies were conducted according to Organization for Economic co-Operation and Development 423 guidelines. The EEMTL found to be nontoxic up to 2000 mg/kg. 13 
Experimental animals
All the animals were procured from the central animal house, S. N. Medical College, Bagalkot. Wistar albino rats of either gender weighing 150-250 g were selected for the experiment. Pregnant rats, animals with an infection, animals with injuries, deformities were excluded from the study. Prior to and during study, all the animals were maintained under standard animal house conditions at 12:12 hrs dark:light cycle, at temperature 25±2°C, 35-60% humidity and other micro and macro environment conditions as suggested by Committee for the Purpose of Control and Supervision of Experiment on Animals (CPCSEA). All animals were housed in a polypropylene cage covered with a stainless steel wire mesh and a paddy husk bed, with adequate provision for feed and water. All the animals were maintained on standard laboratory diet (VRK Nutritionals, Pune) and water was provided ad-libitum.
The study was started after getting the Institutional Animal Ethics Committee Approval (IAEC/SNMC Reg No.829/ AC/04/CPCSEA).
Maximal electro shock induced seizures (MES)
This model was developed by Merritt and Putnam in 1938. 14 This model is helpful in the screening of drugs effective against primary and secondary generalized tonic clonic seizure (GTCS).
14,15
The animals were divided into five groups with each group consisting of six animals. Group I received normal saline 0.5ml/kg served as control, Group II received phenytoin sodium (25 mg/kg, intraperitoneal [ip]) as standard in MES method. Group III, IV, V were administered three graded doses of test drug (EEMTL), i.e., 100, 200, 400 mg/kg, orally in MES experimental models. In MES model, convulsions were produced in all groups by giving maximal electric shock of 150 mA for 0.2 sec after 1 hr of giving test extract orally and standard drug ip., tonic-clonic seizures were produced after giving electric shock. Time duration (in sec) of each phase, i.e., tonus, clonus, stupor was noted and compared with control
Statistical analysis
The data were expressed as mean±standard deviation and statically analyzed using one-way analysis of variance followed by Dunnett's multiple comparison tests. For all the tests a p=0.05 or less was considered as a statistical significance.
RESULTS
Acute oral toxicity study
No adverse effect or mortality was detected in Swiss albino mice at 2 g/kg of EEMTL. All the animals were alive, healthy and active during the observational period of 14-day. Hence, the LD 50 was considered as >2000 mg/kg.
Phytochemical constituents
Preliminary phytochemical studies of EEMTL showed the presence of flavonoids, triterpenoids, steroids and carbohydrates.
Present study has shown EEMTL when given in a dose of 200 mg/kg and 400 mg/kg significantly reduced duration of hindlimb extension with mean of (6.45±0.63* and 4.54±0.72*; p<0.0001), respectively, in MES-induced seizure model (Table 1 and Figure 1 ) when compared to control (22.4±3.64). Thus EEMTL (200 mg/kg and 400 mg/kg) has protection against MES.
DISCUSSION
The recent trend in human healthcare is to use more of plant derived products for prevention and therapy of various diseases. Indian herbs have the potential to become the first-line therapies for diseases with unmet medical needs. 16 However, most of the antiepileptic drugs are inaccessible, more costly and possess many toxic adverse effects. In this regard, there is a need for the development of safer, efficacious and more economical anticonvulsant agents from plant and other sources.
In the present study, the anticonvulsant action of M. tuberosa leaves extract was evaluated in Wistar albino rats. According to literature, M. tuberosa having a number of medicinal properties like antiulcer, anti-diabetic, hepatoprotective, antidiarrhoeal, and antiepileptic property. The previous studies have shown that EEMTL fruits exhibit significant anticonvulsant activity.
In this study, EEMTL at high dose (400 mg/kg) (4.54±0.72*; p<0.0001) inhibits the type of seizures and shortens the duration of hindlimb extension effectively when compared with control group. High dose (400 mg/kg) is also more effective as that of standard drug (phenytoin sodium). Based on present study results, we conclude that the EEMTL possesses potent anticonvulsant activity. However, further studies are recommended to know the underlying mechanism of anticonvulsant activity and for isolation of active ingredients of the plant.
CONCLUSION
Current research proved that EEMTL has shown protection against maximum electroshock seizures induced convulsion. As MES model is useful for screening drugs effective against GTCS, the EEMTL can be considered for further preclinical evaluation to substantiate its use in GTCS. In the present study, the anticonvulsant activity of M. tuberosa leaves might be attributed to the presence of flavonoids. 
